732 related articles for article (PubMed ID: 29393370)
21. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
22. Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis.
Xu B
Medicine (Baltimore); 2021 Jan; 100(3):e23513. PubMed ID: 33545929
[TBL] [Abstract][Full Text] [Related]
23. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.
Yang A; Wang X; Hu Y; Shang C; Hong Y
Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971
[TBL] [Abstract][Full Text] [Related]
24. Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients.
Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C
DNA Cell Biol; 2019 Jul; 38(7):688-699. PubMed ID: 31188028
[TBL] [Abstract][Full Text] [Related]
25. Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma.
Yin W; Tang G; Zhou Q; Cao Y; Li H; Fu X; Wu Z; Jiang X
Front Genet; 2019; 10():419. PubMed ID: 31130992
[TBL] [Abstract][Full Text] [Related]
26. Screening of differentially expressed genes associated with human glioblastoma and functional analysis using a DNA microarray.
Wang L; Wei B; Hu G; Wang L; Bi M; Sun Z; Jin Y
Mol Med Rep; 2015 Aug; 12(2):1991-6. PubMed ID: 25901754
[TBL] [Abstract][Full Text] [Related]
27. Identification of an autophagy-related 10-lncRNA-mRNA signature for distinguishing glioblastoma multiforme from lower‑grade glioma and prognosis prediction.
Wei B; Wang L; Zhao J
Gen Physiol Biophys; 2021 Jul; 40(4):257-274. PubMed ID: 34350832
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
Bi Y; Wu ZH; Cao F
BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
[TBL] [Abstract][Full Text] [Related]
30. A Potential Prognostic Gene Signature for Predicting Survival for Glioblastoma Patients.
Hou Z; Yang J; Wang H; Liu D; Zhang H
Biomed Res Int; 2019; 2019():9506461. PubMed ID: 31032367
[TBL] [Abstract][Full Text] [Related]
31. A 6‑gene risk score system constructed for predicting the clinical prognosis of pancreatic adenocarcinoma patients.
Liu Y; Zhu D; Xing H; Hou Y; Sun Y
Oncol Rep; 2019 Mar; 41(3):1521-1530. PubMed ID: 30747226
[TBL] [Abstract][Full Text] [Related]
32. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
33. Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technology.
Cui K; Chen JH; Zou YF; Zhang SY; Wu B; Jing K; Li LW; Xia L; Sun C; Dong YL
Technol Cancer Res Treat; 2021; 20():1533033821990368. PubMed ID: 34018447
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis.
Yin X; Wu Q; Hao Z; Chen L
Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
[TBL] [Abstract][Full Text] [Related]
36. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Zhao J; Wang L; Wei B
Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
[TBL] [Abstract][Full Text] [Related]
37. A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
Niyazi M; Pitea A; Mittelbronn M; Steinbach J; Sticht C; Zehentmayr F; Piehlmaier D; Zitzelsberger H; Ganswindt U; Rödel C; Lauber K; Belka C; Unger K
Oncotarget; 2016 Jul; 7(29):45764-45775. PubMed ID: 27302927
[TBL] [Abstract][Full Text] [Related]
38. A novel methylation signature predicts radiotherapy sensitivity in glioma.
Feng Y; Li G; Shi Z; Yan X; Wang Z; Jiang H; Chen Y; Li R; Zhai Y; Chang Y; Zhang W; Yuan F
Sci Rep; 2020 Nov; 10(1):20406. PubMed ID: 33230136
[TBL] [Abstract][Full Text] [Related]
39. A 4-gene panel predicting the survival of patients with glioblastoma.
Guo XX; Su J; He XF
J Cell Biochem; 2019 Sep; 120(9):16037-16043. PubMed ID: 31081973
[TBL] [Abstract][Full Text] [Related]
40. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
Lei CG; Jia XY; Sun WJ
Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
